Robert T. OʼDonnell

Medicine · Health Sciences

34h-index3.8kcitations151works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(50), Lymphoma Diagnosis and Treatment(38), Monoclonal and Polyclonal Antibodies Research(31), Prostate Cancer Treatment and Research(14), Chronic Lymphocytic Leukemia Research(13)

Publications151 total

ISOLATION AND CHARACTERIZATION OF NEUTROPHIL GRANULES AND PLASMA MEMBRANE VESICLES.
Figshare·2025Open Access
Risk Factors for Chronic Post-surgical Pain Following Orthopedic Surgery “Who’s at Risk”
Current anesthesiology reports·2024· 1 cited
Fermented Wheat Germ Protein with Histone Deacetylase Inhibitor AR42 Demonstrates Enhanced Cytotoxicity against Lymphoma Cells In Vitro and In Vivo
International Journal of Molecular Sciences·2024Open Access
505: THE FAST AND THE FURRIEST: A RAPIDLY EVOLVING CASE OF WEIL DISEASE FROM HANDLING RATS
Critical Care Medicine·2023
A Fermented Wheat Germ Extract Contains Protein Components Active against NSCLC Xenografts In Vivo
Current Issues in Molecular Biology·2023· 3 citedOpen Access
Transtracheal jet ventilation
Anaesthesia & intensive care medicine·2023· 1 cited
Airway Management in Pediatric Trauma
2022· 1 cited
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention
JAMA Network Open·2021· 78 citedOpen Access
Meningioma with leptomeningeal dissemination (2586)
Neurology·2021
Surgery, Concurrent Radiation Therapy and Chemotherapy Followed by Injections of Autologous Dendritic Cell Vaccines Pulsed With Wntigens From Self-renewing Autologous Tumor Cells in the Treatment of Primary Glioblastoma
Neurosurgery·2020
Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells
Pharmaceuticals·2020· 8 citedOpen Access
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
UNC Libraries·2020Open Access
CTNI-77. EF-19, A POST-APPROVAL REGISTRY STUDY OF TUMOR TREATING FIELDS (TTFIELDS) IN RECURRENT GLIOBLASTOMA (rGBM)
Neuro-Oncology·2020· 4 citedOpen Access
319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine
Regular and Young Investigator Award Abstracts·2020Open Access
CTIM-26. PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL
Neuro-Oncology·2020Open Access
EF-19: A Post-Approval Registry Study Of Tumor Treating Fields (TTFields) In Recurrent Glioblastoma (rGBM)
International Journal of Radiation Oncology*Biology*Physics·2020· 1 cited
Abstract CT182: Adjunctive treatment of primary glioblastoma with patient-specific dendritic cell vaccines pulsed with antigens from self-renewing autologous tumor cells: A phase II trial
Cancer Research·2020
Abstract CT211: EF-19 - A post-approval registry study of TTFields for the treatment of recurrent glioblastoma (GBM)
Cancer Research·2020
Novel mTORC1 inhibitors kill Glioblastoma stem cells
2020· 5 citedOpen Access
Management of shock in trauma
Anaesthesia & intensive care medicine·2020
page 1 of 8Next →

Frequent Co-authors

Sally J. DeNardo(30), Gerald L. DeNardo(29), David L. Kukis(17), Sui Shen(15), Linda A. Kroger(14), Carol M. Richman(12), Joseph M. Tuscano(12), Kathleen R. Lamborn(11), Gary R. Mirick(10), Claude F. Meares(8), Laird Miers(6), Aina Yuan(6), D. Goldstein(6), Primo N. Lara(5), Frederick J. Meyers(5), David R. Gandara(4), Kit S. Lam(4), D S Goldstein(4), Diane A. DeNardo(4), A. Yuan(4)